Malignant Endometrial Neoplasm — Research

Malignant Endometrial Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-14	27,920	`("Malignant Endometrial Neoplasm"[tiab] OR "Endometrial Cancer"[tiab] OR "Malignant neoplasm of endometrium"[tiab])`	2026-09-14	pubmed
Last 5 years	2021-01-01 → 2026-12-31	10,293	`("Malignant Endometrial Neoplasm"[tiab] OR "Endometrial Cancer"[tiab] OR "Malignant neoplasm of endometrium"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-14	pubmed
Last 12 months	2025-09-14 → 2026-09-14	2,210	`("Malignant Endometrial Neoplasm"[tiab] OR "Endometrial Cancer"[tiab] OR "Malignant neoplasm of endometrium"[tiab]) AND (2025/09/14:2026/09/14[dp])`	2026-09-14	pubmed

Data updated 16 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (28)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 28 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
· J Clin Oncol · 2009 · PMID 19470935 · validated civic_curation pubmed
Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.
· Am J Obstet Gynecol · 2005 · PMID 15746676 · validated civic_curation pubmed
Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer.
· Int J Clin Exp Pathol · 2015 · PMID 26617739 · validated civic_curation pubmed
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.